BiotechTube

Muntelukast + Placebo

Phase 3UNKNOWN
0 views this week 0 watching💤 Quiet
Interest: 36/100
36
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Upper Respiratory Tract Infection

Conditions

Upper Respiratory Tract Infection

Trial Timeline

Nov 1, 2007 → Jun 1, 2010

NCT ID
NCT00551382

About Muntelukast + Placebo

Muntelukast + Placebo is a phase 3 stage product being developed by Merck for Upper Respiratory Tract Infection. The current trial status is unknown. This product is registered under clinical trial identifier NCT00551382. Target conditions include Upper Respiratory Tract Infection.

What happened to similar drugs?

6 of 14 similar drugs in Upper Respiratory Tract Infection were approved

Approved (6) Terminated (1) Active (8)
✅Remimazolam TosilateJiangsu Hengrui MedicineApproved
✅BOTOXAbbVieApproved
✅Montelukast + PlaceboMerckApproved
✅diclofenac potassium + nimesulideNovartisApproved
✅Diclofenac gelNovartisApproved
✅AboBoNT-A + OnaBoNT-AIpsenApproved
🔄IFF flavor 316 282, Paracetamol, PseudoephedrineNovartisPhase 3

Hype Score Breakdown

Clinical
17
Activity
4
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00551382Phase 3UNKNOWN

Competing Products

20 competing products in Upper Respiratory Tract Infection

See all competitors
ProductCompanyStageHype Score
Nivolumab 100 MG in 10 ML InjectionOno PharmaceuticalPhase 2
31
Remimazolam TosilateJiangsu Hengrui MedicineApproved
43
ABBV-950 + BOTOX + Placebo for ABBV-950AbbViePhase 1
21
BOTOX + Placebo for BOTOXAbbViePhase 2
35
BOTOXAbbVieApproved
43
MK-3475 and BCGMerckPhase 2
42
Montelukast + PlaceboMerckApproved
43
IFF flavor 316 282, Paracetamol, PseudoephedrineNovartisPhase 3
40
Paracetamol (500 mg)/dimethindene maleate (1 mg)/ phenylephrine hydrochloride (10 mg) tablets + Paracetamol (500 mg) tabletsNovartisPhase 3
40
diclofenac potassium + nimesulideNovartisApproved
35
Diclofenac gelNovartisApproved
43
IFF flavor 316 282, Paracetamol , Phenylephrine, GuaifenesinNovartisPhase 3
40
Domvanalimab + Zimberelimab + Capecitabine + Fluorouracil + Leucovorin + Oxaliplatin + NivolumabGilead SciencesPhase 3
44
Azithromycin SRPfizerPhase 3
40
NivolumabBristol Myers SquibbPre-clinical
26
NivolumabBristol Myers SquibbPre-clinical
26
REGN475/SAR164877 + Placebo (for REGN475/SAR164877)Regeneron PharmaceuticalsPhase 2
27
IPN10200 + IPN10200 Placebo + DysportIpsenPhase 1/2
36
AboBoNT-A + OnaBoNT-AIpsenApproved
40
Botulinum toxin type AIpsenPhase 3
37